Tego Cyber (TGCB) POS AM 1 Jul 22 Prospectus update (post-effective amendment) Financial data

Cover

Cover	9 Months Ended
	Mar. 31, 2022
Cover [Abstract]
Entity Registrant Name	TEGO CYBER INC.
Entity Central Index Key	0001815632
Document Type	S-1
Amendment Flag	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Filer Category	Non-accelerated Filer
Entity Ex Transition Period	false
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	84-2678167
Entity Address Address Line 1	8565 South Eastern Avenue
Entity Address Address Line 2	Suite 150
Entity Address City Or Town	Las Vegas
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89123
City Area Code	855
Local Phone Number	939-0100

INTERIM CONDENSED BALANCE SHEET

INTERIM CONDENSED BALANCE SHEET - USD ($)	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Current Assets
Cash	$ 522,800	$ 583,015	$ 81,872
Accounts Receivable	1,150	1,450	150
Prepaid Expenses	138,098	113,462	0
Total Current Assets	662,048	697,927	82,022
Computer equipment, net	2,939	0
Software	319,400	75,750	21,500
TOTAL ASSETS	984,387	773,677	103,522
Current Liabilities
Accounts Payable And Accrued Liabilities	31,275	23,010	15,554
Due To Related Parties		0	1,358
Convertible Debts	0	22,621	0
TOTAL LIABILITIES	31,275	45,631	16,912
SHAREHOLDERS' EQUITY
Common Stock Value	25,108	18,297	12,406
Additional Paid In Capital	3,836,136	1,720,631	175,906
Subscriptions Receivable		(10,500)	(24,500)
Accumulated Deficit	(2,908,132)	(1,000,382)	(77,202)
TOTAL SHAREHOLDERS' EQUITY	953,112	728,046	86,610
TOTAL LIABILITIES & SHAREHOLDERS' EQUITY	$ 984,387	$ 773,677	$ 103,522

INTERIM CONDENSED BALANCE SHE_2

INTERIM CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
INTERIM CONDENSED BALANCE SHEET
Common Stock, Authorized	50,000,000	50,000,000	50,000,000
Common Stock, Par Value	$ 0.001	$ 0.001	$ 0.001
Common Stock, Issued	25,108,044	18,296,511	0
Common Stock, Outstanding	25,108,044	18,296,511	0

INTERIM CONDENSED STATEMENT OF

INTERIM CONDENSED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		10 Months Ended	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue
Consulting Fees	$ 0	$ 900	$ 1,050	$ 4,700	$ 2,325	$ 5,600
Subscription services	2,500	0	2,500	0
Subscription Revenue					0	2,500	$ 0
Total Revenue	2,500	900	3,550	4,700	2,325	8,100
Operating Expenses
Advertising and Promotion	30,407	11,062	120,690	30,607	13,944	62,238
Amortization	1,238	0	1,562	0
Contractors and consultants	159,562	3,400	399,813	3,400	263	95,938
Interest and bank charges	346	3,814	6,082	5,547
Insurance	0	0	6,920	0
Investor relations and shareholder communication	59,136	2,749	180,064	5,498	0	67,597
Bank charges & fees					777	3,199
Exchange & listing fees					0	47,176
Interest On Short-term Debt					0	9,865
Legal and accounting	45,435	17,820	197,442	101,810	26,429	168,077
Management Fees	29,250	49,500	156,750	106,000	34,700	167,250
Share based compensation	386,449	0	386,449	0
Meals & entertainment	8,434	750	20,775	1,242	268	4,138
Office and administration	232	1,107	6,770	3,357	798	9,569
Subscriptions and dues	176	283	3,331	579	493	1,672
Rent & utilities					351	488
Transfer agent and filing fees	10,805	35,250	32,009	44,246
Software subscription and platform costs	19,348	0	53,738	0
Travel & hotel					677	1,794
Website & platform cost					827	35,917
Wages and benefits	121,110		272,773
TOTAL OPERATING EXPENSES	874,018	125,735	1,845,168	302,286	79,527	674,918
LOSS FROM OPERATIONS	(871,518)	(124,835)	(1,841,618)	(297,586)
OTHER INCOME (EXPENSE)
Accretion Expense		(59,213)	(66,132)	(71,724)	0	(168,638)	0
Financing fees		(15,482)		(26,966)	0	26,966	0
Gain On Extinguishment Of Convertible Debt					0	36,731	0
Loss On Settlement Of Convertible Debts					0	(97,489)	0
TOTAL OTHER INCOME (EXPENSE)		(74,695)	(66,132)	(98,690)	0	(256,362)	$ 0
NET LOSS	$ (871,518)	$ (199,530)	$ (1,907,750)	$ (396,276)	$ (77,202)	$ (923,180)
BASIC AND DILUTED LOSS PER COMMON SHARE	$ (0.04)	$ (0.02)	$ (0.09)	$ (0.03)	$ (0.01)	$ (0.07)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	19,412,280	13,152,503	22,440,139	12,964,601	7,790,648	13,566,628

INTERIM CONDENSED STATEMENT O_2

INTERIM CONDENSED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended		10 Months Ended	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Cash Flows From Operating Activities
Net Loss For The Year	$ (1,907,750)	$ (396,276)	$ (77,202)	$ (923,180)
Items Not Affecting Cash
Accretion expense on convertible debts	66,132	71,725	0	168,638
Amortization	1,562	0
Financing fees	0	26,965	0	26,966
Interest On Short Term Debt	4,962	0	0	8,567
Shares Issued For Services	132,757	25,000	18,000	74,938
Gain On Extinguishment Of Convertible Debts			0	(36,731)
Shares based compensation	386,449
Loss On Settlement Of Convertible Debts			0	97,489
Changes In Non-cash Working Capital Items:
Accounts receivable	300	(1,000)	(150)	(1,300)
Prepaid expenses	70,057	0	0	(38,400)
Accounts Payable And Accrued Liabilities	8,265	16,336	12,304	45,956
Due To Related Parties			1,358	(1,358)
NET CASH USED IN OPERATING ACTIVITIES	(1,237,266)	(258,608)	(45,690)	(578,415)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of computer equipment	(4,501)	0
Acquisition of software	(243,650)	(39,250)	(18,250)	(54,250)
NET CASH USED IN INVESTING ACTIVITIES	(248,151)	(39,250)	(18,250)	(54,250)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds From Shares Issued	1,425,202	74,000	145,812	1,149,798
Proceeds From Issuance Of Convertible Debt	0	260,000	0	300,000
Repayment Of Convertible Debt			0	(312,240)
Convertible Debt Issuance Costs	0	(28,250)	0	(28,250)
Collection Of Subscription Receivable			0	24,500
Net Cash Provided By Financing Activities	1,425,202	322,250	145,812	1,133,808
Net Increase In Cash	(60,215)	24,392	81,872	501,143	$ 81,872
CASH AT BEGINNING OF THE PERIOD	583,015	81,872	0	81,872
CASH AT END OF THE PERIOD	522,800	106,264	81,872	583,015	81,872
Non-cash Investing And Financing Activities:
Software included in accounts payable and accrued liabilities	0	5,000	3,250	0
Shares Issued Included In Subscriptions Receivable			24,500	10,500
Shares Issued For Prepaid Expenses	94,693	0	0	75,062
Shares Issued For Settlement Of Debt			0	38,500
Shares Issued With Convertible Debts	0	33,000	0	33,000	0
Collection of subscription receivable	0	16,500
Equity Portion Of Convertible Debts	0	124,453	0	10,167	0
Warrants Issued With Convertible Debt	$ 0	$ 88,818	$ 0	$ 158,651	$ 0

INTERIM CONDENSED STATEMENT O_3

INTERIM CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Subscriptions Receivable	Accumulated Deficit	Subscription Receivable
Beginning Balance, Shares at Jun. 30, 2019		0
Beginning Balance, Amount at Jun. 30, 2019		$ 0	$ 0	$ 0	$ 0
Shares Issued To Founders For Services, Shares		8,000,000
Shares Issued To Founders For Services, Amount	$ 8,000	$ 8,000
Private Placement, Shares		3,406,236
Private Placement, Amount		$ 3,406	166,906		0
Shares Issued For Services, Shares		1,000,000
Shares Issued For Services, Amount	10,000	$ 1,000	9,000
Shares Issued As Transaction Costs For Debt, Amount	0
Equity Portion Of Convertible Debt	0
Warrants Issued With Convertible Debts	0
Ending Balance, Amount at Jun. 30, 2020	86,610	$ 12,406	175,906	(24,500)	(77,202)	$ (24,500)
Balance, shares at Jun. 30, 2020		12,406,236
Ending Balance, Shares at Jun. 30, 2020		12,406,236
Private Placement, Shares		696,000
Private Placement, Amount	90,500	$ 696	73,304		0	16,500
Shares Issued For Services, Shares		100,000
Shares Issued For Services, Amount	25,000	$ 100	24,900			0
Shares issued as transaction costs for convertible debts, shares		198,000
Shares Issued As Transaction Costs For Debt, Amount	33,000	$ 198	32,802		0	0
Equity Portion Of Convertible Debt	124,453	0	124,453		0	0
Warrants Issued With Convertible Debts	88,818	0	88,818		0	0
Net loss for period	(396,276)	0	0		(396,276)	0
Share based compensation	0
Ending Balance, Amount at Mar. 31, 2021	52,105	$ 13,400	520,183		(473,478)	(8,000)
Balance, shares at Mar. 31, 2021		13,400,236
Beginning Balance, Shares at Jun. 30, 2020		12,406,236
Beginning Balance, Amount at Jun. 30, 2020	86,610	$ 12,406	175,906	(24,500)	(77,202)	(24,500)
Balance, shares at Jun. 30, 2020		12,406,236
Private Placement, Shares		5,041,190
Private Placement, Amount		$ 5,042	1,155,256
Shares Issued For Services, Shares		299,752
Shares Issued For Services, Amount	74,938	$ 300	74,638
Shares issued as transaction costs for convertible debts, shares		198,000
Shares Issued As Transaction Costs For Debt, Amount	33,000	$ 198	32,802
Equity Portion Of Convertible Debt	10,167		10,167
Warrants Issued With Convertible Debts	158,651		158,651
Shares Issued As Prepaid Expense, Amount	75,062	$ 300	74,762
Shares Issued For Settlement Of Debt, Shares		51,085
Net loss for period	(923,180)
Shares Issued For Settlement Of Debt, Amount	38,500	$ 51	38,449
Shares Issued As Prepaid Expense, Shares		300,248
Ending Balance, Amount at Jun. 30, 2021	728,046	$ 18,297	1,720,631	$ (10,500)	(1,000,382)	(10,500)
Balance, shares at Jun. 30, 2021		18,296,511
Ending Balance, Shares at Jun. 30, 2021		18,296,511
Shares Issued To Founders For Services, Shares		5,558,810
Shares Issued To Founders For Services, Amount	1,425,202	$ 5,559	1,409,143		0	10,500
Shares Issued For Services, Shares		179,550
Shares Issued For Services, Amount	132,758	$ 180	132,578		0	0
Shares Issued As Transaction Costs For Debt, Amount	0
Equity Portion Of Convertible Debt	0
Warrants Issued With Convertible Debts	0
Shares Issued For Settlement Of Debt, Shares		937,151
Net loss for period	(1,907,750)	$ 0	0		(1,907,750)	0
Shares Issued For Settlement Of Debt, Amount	93,715	$ 937	92,778		0	0
Shares Issued As Prepaid Expense, Shares		136,022
Shares issued as prepaid expenses, amount	94,692	$ 135	94,557		0	0
Share based compensation	386,449	0	386,449		0	0
Ending Balance, Amount at Mar. 31, 2022	$ 953,112	$ 25,108	$ 3,836,136		$ (2,908,132)	$ 0
Balance, shares at Mar. 31, 2022		25,108,044

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
ORGANIZATION AND DESCRIPTION OF BUSINESS
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Tego Cyber Inc. (the “Company”) was incorporated on September 6, 2019 in the State of Nevada. The Company was created to capitalize on the emerging cyber threat intelligence market. It has developed a cyber threat intelligence application that integrates with top end security platforms to gather, analyze, then proactively identify threats to an enterprise network. The Tego Guardian Threat Intelligence Platform takes in vetted and curated threat data and after utilizing a proprietary process, the platform compiles, analyzes, and then delivers that data to an enterprise network in a format that is timely, informative, and relevant. The threat data provides additional context including specific details needed to identify and counteract threats so that security teams can spend less time searching for disparate information. The first version of the application integrated with the widely accepted Splunk SIEM to provide real-time threat intelligence to macro enterprises using the Splunk architecture. The Company plans on developing future versions of the Tego Guardian app for integration with other established SIEM systems and platforms including: Elastic, IBM QRadar, AT&T Cybersecurity, Exabeam, and Google Chronical. The Company also offer advanced cybersecurity consulting services including vulnerability assessments, penetration testing, vCISO services, dark web monitoring, cybersecurity policy creation and employee training. The Company’s head office is at 8565 S. Eastern Ave. #150, Las Vegas, Nevada, 89123.	NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS Tego Cyber Inc. (the “Company”) was incorporated on September 6, 2019 in the State of Nevada. The Company has developed an automated threat intelligence defense platform that provides real-time protection against cyber-threats. The Company is focused on filling the cyber-security skills gap with automated cyber defense solutions, including a monthly software subscription to users of the multiple router and firewall manufacturers. The Company’s head office is at at 8565 S. Eastern Ave. #150, Las Vegas, Nevada, 89123.

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
ORGANIZATION AND DESCRIPTION OF BUSINESS
BASIS OF PRESENTATION	NOTE 2 – BASIS OF PRESENTATION The accompanying interim condensed financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted pursuant to US GAAP rules and regulations for presentation of interim financial information. Therefore, the unaudited interim condensed financial statements should be read in conjunction with the financial statements and the notes thereto, included in the Company’s audited financial statements for the year ended June 30, 2021. Current and future financial statements may not be directly comparable to the Company’s historical financial statements. However, except as disclosed herein, there have been no material changes in the information disclosed in the notes to the financial statements for the year ended June 30, 2021. In the opinion of management, all adjustments considered necessary for a fair presentation, consisting solely of normal recurring adjustments, have been made. Operating results for the nine months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the year ending June 30, 2022.	NOTE 2 – BASIS OF PRESENTATION The accompanying audited financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). In the opinion of management, the financial statements include all adjustments of a normal recurring nature necessary for a fair statement of the results for the period presented. The accompanying financial statements have been prepared to present the balance sheet, the statement of operations and comprehensive loss, statement of changes in shareholders’ equity and the statement of cash flows of the Company for the year ended June 30, 2021. The accompanying audited financial statements have been prepared in accordance with US GAAP using Company-specific information where available and allocations and estimates where data is not maintained on a Company-specific basis within its books and records. Due to the allocations and estimates used to prepare the financial statements, they may not reflect the financial position, cash flows and results of operations of the Company in the future or its operations, cash flows and financial position. The preparation of financial statements in accordance with US GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company’s financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions and could have a material effect on the reported amounts of the Company’s financial position and results of operations.

GOING CONCERN UNCERTAINTY

GOING CONCERN UNCERTAINTY	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
GOING CONCERN UNCERTAINTY
GOING CONCERN UNCERTAINTY	NOTE 3 – GOING CONCERN UNCERTAINTY The accompanying unaudited interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At March 31, 2022, the Company had a working capital surplus of $630,773 and has an accumulated deficit of $2,908,132. For the period ended March 31, 2022, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.	NOTE 3 – GOING CONCERN UNCERTAINTY The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of the business. The Company has incurred material losses from operations and has an accumulated deficit. At June 30, 2021, the Company had a working capital surplus of $652,296. For the year ended June 30, 2021, the Company sustained net losses and generated negative cash flows from operations. In March 2020, the World Health Organization recognized the outbreak of COVID-19 as a global pandemic. The COVID-19 pandemic and government actions implemented to contain the further spread of COVID-19 have severely restricted economic activity around the world. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that may be necessary should the Company be unable to continue as a going concern. These adjustments could be material. The Company’s continuation as a going concern is contingent upon its ability to earn adequate revenues from operations and to obtain additional financing. There is no assurance that the Company will be able to obtain such financings or obtain them on favorable terms.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies is presented to assist in understanding the interim condensed financial statements. The interim condensed financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the interim condensed financial statements. Basis of Preparation The accompanying interim condensed financial statements have been prepared to present the balance sheet, the statement of operations and comprehensive loss, statement of changes in shareholders’ equity and statement of cash flows of the Company for the nine-month period ended March 31, 2022 and have been prepared in accordance with US GAAP. Use of Estimates In preparing the interim condensed financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the interim condensed financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at March 31, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary. Cash Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value. Receivables and Allowance for Doubtful Accounts Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the nine-month period ended March 31, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of March 31, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers. Software Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not depreciated until it is available for use by the Company. Leases The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables, convertible debts, and warrants. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at the period ended. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them. Revenue Recognition Revenue from providing consulting and management services is recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements: - executed contracts with the Company’s customers that it believes are legally enforceable; - identification of performance obligations in the respective contract; - determination of the transaction price for each performance obligation in the respective contract; - allocation of the transaction price to each performance obligation; and - recognition of revenue only when the Company satisfies each performance obligation. These five elements as applied to the Company’s consulting services results in revenue recorded as services are provided. Income Taxes The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities. Foreign Currency Translation The Company’s functional and reporting currency is United States dollars (“USD”). The Company maintains its financial statements in the functional currency. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss). Earnings (Loss) per Share Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings per share. The Company had no dilutive securities for the three-month and nine-month period ended March 31, 2022. Recently Issued Accounting Pronouncements Recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company’s present or future financial statements.	NOTE 4 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies is presented to assist in understanding the financial statements. The financial statements and notes are representations of the Company’s management, who are responsible for their integrity and objectivity. These accounting policies conform to US GAAP and have been consistently applied in the preparation of the financial statements. Basis of Preparation The accompanying financial statements have been prepared to present the balance sheet, the statement of operations and comprehensive loss, statement of changes in shareholders’ equity and statement of cash flows of the Company for the period ended June 30, 2021 and have been prepared in accordance with US GAAP. Use of Estimates In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at June 30, 2021, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary. Cash Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value. Receivables and Allowance for Doubtful Accounts Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2021, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2021, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers. Software Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not depreciated until it is available for use by the Company. Leases The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. As at June 30, 2021, the Company had no leases. Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Fair Value of Financial Instruments (continued) Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at June 30, 2021. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them. Revenue Recognition Revenue from providing consulting and management services is recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements: - executed contracts with the Company’s customers that it believes are legally enforceable; - identification of performance obligations in the respective contract; - determination of the transaction price for each performance obligation in the respective contract; - allocation of the transaction price to each performance obligation; and - recognition of revenue only when the Company satisfies each performance obligation. These five elements as applied to the Company’s consulting services results in revenue recorded as services are provided. Income Taxes The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities. Foreign Currency Translation The Company’s functional and reporting currency is United States dollars (“USD”). The Company maintains its financial statements in the functional currency. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss). Earnings (Loss) per Share Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. The Company had no dilutive securities for the year ended June 30, 2021. Recently Issued Accounting Pronouncements In December 2019, the FASB issued ASU 2019-2, Simplifying the Accounting for Income Taxes Income Taxes Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company's present or future financial statements.

SOFTWARE

SOFTWARE	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SOFTWARE
SOFTWARE	NOTE 5 – SOFTWARE Balance, June 30, 2020 $ 21,500 Additions 54,250 Depreciation - Balance, June 30, 2021 75,750 Additions 243,650 Depreciation - Balance, March 31, 2022 $ 319,400 As at March 31, 2022, the software is not yet being used or generating revenue and therefore no depreciation has been recorded.	NOTE 5 – SOFTWARE Balance, September 6, 2019 (Date of Inception) $ - Additions 21,500 Depreciation - Balance, June 30, 2020 21,500 Additions 54,250 Depreciation - Balance, June 30, 2021 $ 75,750 As at June 30, 2021 and 2020, the software is not in use and no depreciation has been recorded for the periods then ended.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6 – RELATED PARTY TRANSACTIONS Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences. During the nine month period ended March 31, 2022, there were transactions incurred between the Company and Shannon Wilkinson, Director, CEO, CFO, Secretary and Treasurer of the Company, for management fees and contractor fees for a total of $66,500 (March 31, 2021 - $81,000) and net wages of $34,099 (March 31, 2021 - $Nil). During the nine month period ended March 31, 2022, there were transactions incurred between the Company and Troy Wilkinson, Director and President of the Company, for management fees and contractor fees for a total of $107,500 (March 31, 2021 - $Nil). During the nine month period ended March 31, 2021, there were transactions incurred between the Company and Chris White, Director and CISO of the Company, for management fees of $12,500 (March 31, 2021 - $Nil) and net wages of $25,620 (March 31, 2021 - $Nil).	NOTE 6 – RELATED PARTY TRANSACTIONS Related party transactions are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Related parties are natural persons or other entities that have the ability, directly, or indirectly, to control another party or exercise significant influence over the party in making financial and operating decisions. Related parties include other parties that are subject to common control or that are subject to common significant influences. On the date of incorporation 8,000,000 shares were issued to directors and founders at par value as per the following in exchange for concept and services valued at $8,000: Shannon Wilkinson, Director, CEO, CFO, Secretary, Treasurer: 3,000,000; Troy Wilkinson, Director, President: 3,000,000; Michael De Valera, Director: 1,000,000; and Stephen Seminew, Co-Founder 1,000,000. During the year ended June 30, 2021, there were transactions incurred between the Company and Shannon Wilkinson, Director, CEO, CFO, Secretary and Treasurer for management fees of $134,750 (June 30, 2020 - $29,700) and reimbursement of expenses incurred on behalf of the Company. As of June 30, 2021, included in due to related parties, is $Nil (June 30, 2020 - $1,308) due to this officer. During the year ended June 30, 2021, there were transactions incurred between the Company and Chris White, Director and President of the Company for management fees of $32,500 (June 30, 2020 - $Nil). As of June 30, 2021, included in due to related parties, is $Nil (June 30, 2020 - $Nil) due to this officer. During the year ended June 30, 2021, there were transactions incurred between the Company and other related parties for management fees of $Nil (June 30, 2020 - $5,000) and reimbursement of expenses incurred on behalf of the Company. As of June 20, 2021, included in due to related parties, is $Nil (June 30, 2020 - $50) due to them.

COMMON SHARES

COMMON SHARES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SHAREHOLDERS' EQUITY
COMMON SHARES	NOTE 7 – COMMON SHARES Common Stock At March 31, 2022, the Company’s authorized capital consisted of 50,000,000 of common shares with a $0.001 par value and 25,108,044 shares were issued and outstanding. During the nine month period ended March 31, 2022, the Company incurred the following transactions: During the nine month period ended March 31, 2022, the Company completed various private placements whereby a total of 5,458,810 common shares were issued at a price of $0.25 and 100,000 common shares were issued at a price of $0.50 per share for a total value of $1,425,202. On October 15, 2021, the Company issued 125,000 common shares at a price of $0.80 per share for prepaid marketing services valued at $100,000. During the nine month period ended March 31, 2022, $75,138 was amortized and recorded as advertising and promotion expenses. On October 28, 2021, the Company issued 28,572 common shares at a price of $0.70 per share for legal services valued at $20,000. On December 8, 2021, the Company issued 50,000 common shares at a price of $0.71 per share for prepaid consulting services valued at $35,250. During the nine month period ended March 31, 2022, $14,526 was amortized and recorded as consulting expenses. On December 31, 2021, the Company issued 937,151 common shares for the conversion of debt at a conversion price of $0.10 per share for a total value of $93,715. (Note 8) On January 1, 2022, the Company issued 100,000 common shares at a price of $0.65 per share for prepaid consulting services valued at $65,000. During the nine month period ended March 31, 2022, $15,893 was amortized and recorded as consulting expenses. On March 25, 2022, the Company issued 12,000 common shares at a price of $0.60 per share for services valued at $7,200. During the nine month period ended March 31, 2021, the Company incurred the following transactions: During the period from July 2, 2020 to July 31, 2020, the Company completed various private placements whereby a total of 500,000 common shares were issued at a price of $0.05 per share for a total value of $25,000. During the period from November 24, 2020 to March 31, 2021, the Company completed various private placements whereby a total of 196,000 common shares were issued at a price of $0.25 per share for a total value of $49,500. On December 28, 2020, the Company issued 110,000 shares to a non-related party at a price of $0.10 per share for a total value of $11,000 as commitment shares in exchange for services related to the issuance of convertible debt on Note 8 (b). On March 29, 2021, the Company issued 88,000 shares to a non-related party at a price of $0.25 per share for a total value of $12,000 as debt issuance costs related to the issuance of convertible debt on Note 8 (c). On March 29, 2021, the Company issued 100,000 shares to a director of the Company at a price of $0.25 per share for a total value of $25,000 in exchange for services. Warrants On December 28, 2020, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (b)). The warrants were valued at $145,744 using the Black Scholes Option Pricing Model. On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (c)). The warrants were valued at $147,266 using the Black Scholes Option Pricing Model. On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (a)). The warrants were valued at $399,087 using the Black Scholes Option Pricing Model. On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (a)). The warrants were valued at $196,399 using the Black Scholes Option Pricing Model. The following is a continuity schedule for the Company’s outstanding warrants: Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2021 3,014,246 $ 0.25 Granted - - Exercised - - Expired - - Outstanding, March 31, 2022 3,014,246 $ 0.25 Stock Options On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company , During the nine month period ended March 31, 2022 the Company issued a total of 6,000,000 non-qualified stock options (the “options”) to directors, officers and certain key consultants. The options are subject to the terms and conditions of the Equity Compensation Plan. All granted options are subject to a five-year vesting schedule equal to 20% per year starting on the 1 st The following is a continuity schedule for the Company’s outstanding non-qualified stock options: Number of options Weighted average exercise price Outstanding, June 30, 2021 - USD - Granted 6,000,000 USD 0.65 Exercised - USD - Cancelled - USD - Outstanding, March 31, 2021 6,000,000 USD 0.65 As at March 31, 2022, the Company had the following stock options outstanding: Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (years) Expiry Date January 3, 2022 125,000 - USD 0.65 9.77 January 3, 2032 January 4, 2022 5,875,000 - USD 0.65 9.77 January 4, 2032 Total 6,000,000 - USD 0.65 9.77 During the period ended March 31, 2022, the Company recorded $386,449 as share-based compensation. The fair value of the options granted during the nine month period ended March 31, 2022 was estimated on the date of the grant date using the Black-Scholes option pricing model with the following weighted average assumptions: Expected volatility 106.83 % Expected option life (years) 10 Risk-free interest rate (10-year U.S. treasury yield) 1.63 - 1.66 % Expected dividend yield 0 % Performance Stock Units On December 8, 2021, the Board of Directors of the Company approved the adoption of the 2021 Equity Compensation Plan (the “Equity Compensation Plan”) to provide employees, certain consultants and advisors who perform services for the Company , During the nine month period ended March 31, 2022 the Company issued a total of 4,000,000 performance stock units (“performance units”) to directors, officers and certain key consultants. The performance units are subject to the terms and conditions of the Equity Compensation Plan. The performance units will be earned and vest upon reaching certain market capitalization goals during the performance period ending on December 31, 2026. As of March 31, 2022, none of the performance stock units had vested and $Nil share-based compensation expense was recorded. The following is a continuity schedule for the Company’s outstanding performance stock units: Number of Options Weighted Average Exercise Price Outstanding, June 30, 2021 - $ - Granted 4,000,000 - Released - - Forfeited or cancelled - - Outstanding, March 31, 2022 4,000,000 $ -	NOTE 7 – COMMON SHARES At June 30, 2021, the Company’s authorized capital consisted of 50,000,000 of common shares with a $0.001 par value and 18,296,511 shares were issued and outstanding. During the period ended June 30, 2020, the Company incurred the following transactions: On November 4, 2019, the Company issued 8,000,000 shares to the founders with a fair value of $8,000 in exchange for services. On November 15, 2019, the Company issued 1,000,000 shares to two non-related parties with a fair value of $10,000 in exchange for services. During the period from November 15, 2019 to June 30, 2020, the Company completed various private placements whereby a total of 3,406,236 common shares were issued at a price of $0.05 per share for a total value of $170,312. As at June 30, 2020, $24,500 of the subscriptions still remained receivable. During the year ended June 30, 2021, the Company incurred the following transactions: During the period from July 2, 2020 to July 31, 2020, the Company completed various private placements whereby a total of 500,000 common shares were issued at a price of $0.05 per share for a total value of $25,000. During the period from November 24, 2020 to June 30, 2021, the Company completed various private placements whereby a total of 4,541,190 common shares were issued at a price of $0.25 per share for a total value of $1,135,298. As at June 31, 2021, $10,500 of the subscriptions still remained receivable. On December 28, 2020, the Company issued 110,000 shares to a non-related party at a price of $0.10 per share for a total value of $11,000 as commitment shares in exchange for services related to the issuance of convertible debt on Note 8 (c). On March 29, 2021, the Company issued 88,000 shares to a non-related party at a price of $0.25 per share for a total value of $22,000 as debt issuance costs related to the issuance of convertible debt on Note 8 (d). On March 29, 2021, the Company issued 100,000 shares to a director of the Company at a price of $0.25 per share for a total value of $25,000 in exchange for services. On April 12, 2021, the Company issued 400,000 shares to a non-related party at a price of $0.25 per share for a total value of $100,000 in exchange for services. A portion of the services are yet to be incurred and have been recorded as prepaid expenses for a total value of $56,312. On April 15, 2021, the Company issued 100,000 shares to a non-related party at a price of $0.25 per share for a total value of $25,000 in exchange for services. A portion of the services are yet to be incurred and have been recorded as prepaid expenses for a total value of $18,750. On June 21, 2021, the Company issued 41,085 shares to a non-related party at a price of $0.73 per share for a total value of $30,000 as settlement of debt. On June 25, 2021, the Company issued 10,000 shares to a non-related party at a price of $0.85 per share for a total value of $8,500 as settlement of debt. Warrants On December 28, 2020, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (b)). The warrants were valued at $145,744 using the Black Scholes Option Pricing Model. On March 25, 2021, the Company granted 1,100,000 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (c)). The warrants were valued at $147,266 using the Black Scholes Option Pricing Model. On April 22, 2021, the Company granted 506,838 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (a)). The warrants were valued at $399,087 using the Black Scholes Option Pricing Model. On April 28, 2021, the Company granted 307,408 warrants with a contractual life of two years and exercise price of $0.25 per share to a lender as part of the convertible debt financing transaction (Note 8 (a)). The warrants were valued at $196,399 using the Black Scholes Option Pricing Model. The Black Scholes Option Pricing Model assumptions used in the valuation of the warrants are outlined below. The stock price was based on recent issuances. Expected life was based on the expiry date of the warrants as the Company did not have historical exercise data of such warrants. March 31, 2021 Stock price $0.85 - $0.25 Risk-free interest rate 0.13% - 0.17% Expected life 2 years Expected dividend rate 0% Expected volatility 102.03% - 206.63% Continuity of the Company’s common stock purchase warrants issued and outstanding is as follows: Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2020 - $ - Granted 3,014,246 0.25 Exercised - - Expired - - Outstanding, June 30, 2021 3,014,246 $ 0.25 As at June 30, 2021, the weighted average remaining contractual life of warrants outstanding was 1.21 years with an intrinsic value of $0.25.

COVERTIBLE DEBTS

COVERTIBLE DEBTS	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
COVERTIBLE DEBTS
CONVERTIBLE DEBTS	NOTE 8 – CONVERTIBLE DEBTS (a) On November 10, 2020, the Company issued a convertible debt in the principal amount of $20,000 each in exchange for cash. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days lapsed, is convertible at $0.10 per 1 common share, and has a maturity date of May 10, 2021. The carrying value of beneficial conversion features not considered to be derivative instruments were determined by allocating the intrinsic value of the conversion features from proceeds. As a result, total proceeds of $20,000 were allocated to the beneficial conversion feature, recorded as equity portions of convertible debt and there were no remaining proceeds available for allocation to the liability portion of the convertible debt. The convertible debt was discounted by the amounts allocated to the conversion features. On April 22, 2021, the Company renegotiated the terms of the convertible debt in exchange for a new convertible debt in the principal amount of $55,245 at $50,684, with $4,561 original issue discount, for additional cash proceeds of $30,000 and surrender of the convertible note previously issued. In connection with the note, the Company issued 506,838 warrants exercisable at $0.25 per share, expiring on April 22, 2023. The warrants were calculated to have a relative fair value of $44,088. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days elapsed, is convertible at $0.10 per 1 common share, and matures on January 22, 2022. The terms of the new convertible debt were substantially different and deemed extinguished resulting in a gain of $18,049 recorded on extinguishment of convertible debt. The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion feature not considered to be a derivative instrument was determined by allocating $5,912 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after deducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. On December 31, 2021 the outstanding balance of the convertible debt and accrued interest was converted in exchange for 583,936 common shares at a conversion price of $0.10 per share for a total value of $58,394. As at March 21, 2022, the carrying value of this convertible debt was $nil (June 30, 2021 - $14,374). (b) On November 10, 2020, the Company issued a convertible debt in the principal amount of $20,000 in exchange for cash. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days lapsed, is convertible at $0.10 per 1 common share, and has a maturity date of May 10, 2021. The carrying value of beneficial conversion features not considered to be derivative instruments were determined by allocating the intrinsic value of the conversion features from proceeds. As a result, total proceeds of $20,000 were allocated to the beneficial conversion feature, recorded as equity portions of convertible debt and there were no remaining proceeds available for allocation to the liability portion of the convertible debt. The convertible debt was discounted by the amounts allocated to the conversion features. On April 28, 2021, the Company renegotiated the terms of the convertible debt in exchange for a new convertible debt in the principal amount of $33,508 at $30,741, with $2,767 original issue discount, for additional cash proceeds of $10,000 and surrender of the convertible note previously issued. In connection with the note, the Company issued 307,408 warrants exercisable at $0.25 per share, expiring on April 28, 2023. The warrants were calculated to have a relative fair value of $25,745. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days elapsed, is convertible at $0.10 per 1 common share, and matures on January 28, 2022. The terms of the new convertible debt were substantially different and deemed extinguished resulting in a gain of $18,682 recorded on extinguishment of convertible debt. The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion features not considered to be derivative instruments was determined by allocating $4,255 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after deducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. On December 31, 2021 the outstanding balance of the convertible debt and accrued interest was converted in exchange for 353,215 common shares at a conversion price of $0.10 per share for a total value of $35,321. As at March 31, 2022, the carrying value of this convertible debt was $nil (June 30, 2021 - $8,247).	NOTE 8 – CONVERTIBLE DEBTS (a) On November 10, 2020, the Company issued a convertible debt in the principal amount of $20,000 each in exchange for cash. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days lapsed, is convertible at $0.10 per 1 common share, and has a maturity date of May 10, 2021. The carrying value of beneficial conversion features not considered to be derivative instruments were determined by allocating the intrinsic value of the conversion features from proceeds. As a result, total proceeds of $20,000 were allocated to the beneficial conversion feature, recorded as equity portions of convertible debt and there were no remaining proceeds available for allocation to the liability portion of the convertible debt. The convertible debt was discounted by the amounts allocated to the conversion features. On April 22, 2021, the Company renegotiated the terms of the convertible debt in exchange for a new convertible debt in the principal amount of $55,245 at $50,684, with $4,561 original issue discount, for additional cash proceeds of $30,000 and surrender of the convertible note previously issued. In connection with the note, the Company issued 506,838 warrants exercisable at $0.25 per share, expiring on April 22, 2023. The warrants were calculated to have a relative fair value of $44,088. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days elapsed, is convertible at $0.10 per 1 common share, and matures on January 22, 2022. The terms of the new convertible debt were substantially different and deemed extinguished resulting in a gain of $18,049 recorded on extinguishment of convertible debt. The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion features not considered to be derivative instruments was determined by allocating $5,912 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after deducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. As at June 30, 2021, the carrying value of this convertible debt was $14,374 (June 30, 2020 - $Nil) net of $40,871 unamortized discounts. (b) On November 10, 2020, the Company issued a convertible debt in the principal amount of $20,000 each in exchange for cash. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days lapsed, is convertible at $0.10 per 1 common share, and has a maturity date of May 10, 2021. The carrying value of beneficial conversion features not considered to be derivative instruments were determined by allocating the intrinsic value of the conversion features from proceeds. As a result, total proceeds of $20,000 were allocated to the beneficial conversion feature, recorded as equity portions of convertible debt and there were no remaining proceeds available for allocation to the liability portion of the convertible debt. The convertible debt was discounted by the amounts allocated to the conversion features. On April 28, 2021, the Company renegotiated the terms of the convertible debt in exchange for a new convertible debt in the principal amount of $33,508 at $30,741, with $$2,767 original issue discount, for additional cash proceeds of $10,000 and surrender of the convertible note previously issued. In connection with the note, the Company issued 307,408 warrants exercisable at $0.25 per share, expiring on April 28, 2023. The warrants were calculated to have a relative fair value of $25,745. The convertible debt is unsecured, bears interest at 8% per annum compounded on the basis of a 365-day year and actual days elapsed, is convertible at $0.10 per 1 common share, and matures on January 28, 2022. The terms of the new convertible debt were substantially different and deemed extinguished resulting in a gain of $18,682 recorded on extinguishment of convertible debt. The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion features not considered to be derivative instruments was determined by allocating $4,255 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after deducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. As at June 30, 2021, the carrying value of this convertible debt was $8,247 (June 30, 2020 - $Nil) net of $25,261 unamortized discounts. (c) The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion features not considered to be derivative instruments was determined by allocating $41,961 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after conducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. On June 18, 2021, the Company settled the convertible debt with a payment of $165,360 resulting in a loss on settlement of convertible debt of $41,037. (d) The proceeds were allocated between the convertible debt and warrants on a relative fair value basis, and the issuance costs were proportioned accordingly. The fair value of the convertible debt was calculated using the present value of the debt and related interest at 12% incremental borrowing rate as the discount rate. The warrants were valued using the Black Scholes Option Pricing Model (Note 7). The carrying value of beneficial conversion features not considered to be derivative instruments was determined by allocating $42,492 for the intrinsic value of the conversion features from the remaining proceeds allocated to the convertible debt after conducting the amount allocated to the warrants. As such, there were no remaining proceeds available for allocating to the liability portion of the convertible debt. On June 29, 2021, the Company settled the convertible debt with a payment of $146,880 resulting in a loss on settlement of convertible debt of $56,452.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 9 – COMMITMENTS AND CONTINGENCIES The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.	NOTE 9 – COMMITMENTS AND CONTINGENCIES The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.

INCOME TAXES

INCOME TAXES	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
INCOME TAXES
INCOME TAXES	NOTE 10 – INCOME TAXES As of March 31, 2022, the Company was in a loss position; therefore, no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax. Net operating loss carry forward of the Company, amounted to $2,552,102 for the nine month period ended March 31, 2022 (June 30, 2021 - $741,817). The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2041. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.	NOTE 10 – INCOME TAXES As of June 30, 2021, the Company was in a loss position; therefore no deferred tax liability was recognized related to the undistributed earnings subject to withholding tax. Net operating loss carry forward of the Company, amounted to $701,884 (June 30, 2020 - $79,527) for the period ended June 30, 2021. The net operating loss carry forwards are available to be utilized against future taxable income for years through calendar year 2041. In assessing the reliability of deferred income tax assets, management considers whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled projected future taxable income, and tax planning strategies in making this assessment.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Jun. 30, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS Subsequent to June 30, 2021, the Company completed various private placements whereby a total of 5,458,810 common shares were issued at a price of $0.25 per share for a total value of $1,364,703.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis Of Preparation	The accompanying interim condensed financial statements have been prepared to present the balance sheet, the statement of operations and comprehensive loss, statement of changes in shareholders’ equity and statement of cash flows of the Company for the nine-month period ended March 31, 2022 and have been prepared in accordance with US GAAP.	The accompanying financial statements have been prepared to present the balance sheet, the statement of operations and comprehensive loss, statement of changes in shareholders’ equity and statement of cash flows of the Company for the period ended June 30, 2021 and have been prepared in accordance with US GAAP.
Use Of Estimates	In preparing the interim condensed financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the interim condensed financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.	In preparing financial statements in conformity with US GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements, as well as the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made. However, actual results could differ materially from those estimates.
Concentrations Of Credit Risk	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at March 31, 2022, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.	Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and accounts receivable. As at June 30, 2021, substantially all of the Company’s cash was held by major financial institutions located in the United States, which management believes are of high credit quality. With respect to accounts receivable, the Company extended credit based on an evaluation of the customer’s financial condition. The Company generally did not require collateral for accounts receivable and maintained an allowance for doubtful accounts of accounts receivable if necessary.
Cash	Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.	Cash consists of cash held at major financial institutions and is subject to insignificant risk of changes in value.
Receivables And Allowance For Doubtful Accounts	Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the nine-month period ended March 31, 2022, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of March 31, 2022, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.	Trade accounts receivable are recorded at net realizable value and do not bear interest. No allowance for doubtful accounts was made during the period ended June 30, 2021, based on management’s best estimate of the amount of probable credit losses in accounts receivable. The Company evaluates its allowance for doubtful accounts based upon knowledge of its customers and their compliance with credit terms. The evaluation process includes a review of customers’ accounts on a regular basis. The review process evaluates all account balances with amounts outstanding for more than 60 days and other specific amounts for which information obtained indicates that the balance may be uncollectible. As of June 30, 2021, there was no allowance for doubtful accounts and the Company does not have any off-balance-sheet credit exposure related to its customers.
Software	Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not depreciated until it is available for use by the Company.	Software is stated at cost less accumulated amortization and is depreciated using the straight-line method over the estimated useful life of the asset. The estimated useful life of the asset is 5 years and is not depreciated until it is available for use by the Company.
Leases	The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option.	The Company determines if an arrangement is a lease at inception. Operating and financing right-of-use assets and lease liabilities are included on the balance sheet. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Right-of-use assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses its incremental borrowing rate, based on the information available at the commencement date, in determining the present value of future lease payments. Right-of-use assets include any prepaid lease payments and exclude any lease incentives and initial direct costs incurred. Operating lease expenses are recognized on a straight-line basis over the term of the lease, consisting of interest accrued on the lease liability and depreciation of the right-of-use asset. The lease terms may include options to extend or terminate the lease is it is reasonably certain the Company will exercise that option. As at June 30, 2021, the Company had no leases.
Fair Value Of Financial Instruments	Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables, convertible debts, and warrants. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at the period ended. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.	Accounting Standards Codification (“ASC”) 820 “Fair Value Measurements and Disclosures”, adopted January 1, 2008, defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The Company’s financial instruments include cash, current receivables and payables. These financial instruments are measured at their respective fair values. The three levels are defined as follows: Level 1 - inputs to the valuation methodology are quoted prices for identical assets or liabilities in active markets. Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments. Level 3 - inputs to the valuation methodology are unobservable and significant to the fair value. For cash, accounts receivable, accounts payable and accrued liabilities and due to related parties, it is management’s opinion that the carrying values are a reasonable estimate of fair value because of the short period of time between the origination of such instruments and their expected realization and if applicable, their stated interest rate approximates current rates available. For convertible debts, the carrying values, excluding any unamortized discounts, approximate the respective fair value. The convertible debts have been discounted to reflect their net present value as at June 30, 2021. The carrying values of embedded conversion features not considered to be derivative instruments were determined by allocating the remaining carrying value of the convertible debt after deducting the estimated carrying value of the liability portion. Estimating fair value for warrants require determining the most appropriate valuation model which is dependent on the terms and conditions of the grant. This estimate requires determining the most appropriate inputs to the valuation model including the expected life of the warrant, volatility, dividend yield, and rate of forfeitures and making assumptions about them.
Revenue Recognition	Revenue from providing consulting and management services is recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements: - executed contracts with the Company’s customers that it believes are legally enforceable; - identification of performance obligations in the respective contract; - determination of the transaction price for each performance obligation in the respective contract; - allocation of the transaction price to each performance obligation; and - recognition of revenue only when the Company satisfies each performance obligation. These five elements as applied to the Company’s consulting services results in revenue recorded as services are provided.	Revenue from providing consulting and management services is recognized in a manner that reasonably reflects the delivery of services to customers in return for expected consideration and includes the following elements: - executed contracts with the Company’s customers that it believes are legally enforceable; - identification of performance obligations in the respective contract; - determination of the transaction price for each performance obligation in the respective contract; - allocation of the transaction price to each performance obligation; and - recognition of revenue only when the Company satisfies each performance obligation. These five elements as applied to the Company’s consulting services results in revenue recorded as services are provided.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.	The Company uses the asset and liability method of accounting for income taxes pursuant to ASC 740 “Income Taxes”. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Valuation allowances are provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or that future deductibility is uncertain. The provision for income taxes represents current taxes payable net of the change during the period in deferred tax assets and liabilities.
Foreign Currency Translation	The Company’s functional and reporting currency is United States dollars (“USD”). The Company maintains its financial statements in the functional currency. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss).	The Company’s functional and reporting currency is United States dollars (“USD”). The Company maintains its financial statements in the functional currency. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss).
Earnings (loss) Per Share	Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings per share. The Company had no dilutive securities for the three-month and nine-month period ended March 31, 2022.	Basic earnings (loss) per share is computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. If applicable, diluted earnings (loss) per share assume the conversion, exercise or issuance of all common stock instruments unless the effect is to reduce a loss or increase earnings (loss) per share. The Company had no dilutive securities for the year ended June 30, 2021.
Recently Issued Accounting Pronouncements	Recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company’s present or future financial statements.	In December 2019, the FASB issued ASU 2019-2, Simplifying the Accounting for Income Taxes Income Taxes Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) did not or are not expected to have a material impact on the Company's present or future financial statements.

SOFTWARE (Tables)

SOFTWARE (Tables)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SOFTWARE
Schedule Of Software	Balance, June 30, 2020 $ 21,500 Additions 54,250 Depreciation - Balance, June 30, 2021 75,750 Additions 243,650 Depreciation - Balance, March 31, 2022 $ 319,400	Balance, September 6, 2019 (Date of Inception) $ - Additions 21,500 Depreciation - Balance, June 30, 2020 21,500 Additions 54,250 Depreciation - Balance, June 30, 2021 $ 75,750

COMMON SHARES (Tables)

COMMON SHARES (Tables)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SHAREHOLDERS' EQUITY
Schedule of weighted average assumptions:	Expected volatility 106.83 % Expected option life (years) 10 Risk-free interest rate (10-year U.S. treasury yield) 1.63 - 1.66 % Expected dividend yield 0 %	March 31, 2021 Stock price $0.85 - $0.25 Risk-free interest rate 0.13% - 0.17% Expected life 2 years Expected dividend rate 0% Expected volatility 102.03% - 206.63%
Schedule for the Company's outstanding warrants:	Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2021 3,014,246 $ 0.25 Granted - - Exercised - - Expired - - Outstanding, March 31, 2022 3,014,246 $ 0.25	Number of Warrants Weighted Average Exercise Price Outstanding, June 30, 2020 - $ - Granted 3,014,246 0.25 Exercised - - Expired - - Outstanding, June 30, 2021 3,014,246 $ 0.25
Schedule for the Company's outstanding non-qualified stock options:	Number of options Weighted average exercise price Outstanding, June 30, 2021 - USD - Granted 6,000,000 USD 0.65 Exercised - USD - Cancelled - USD - Outstanding, March 31, 2021 6,000,000 USD 0.65
Schedule of stock options outstanding:	Grant Date Number Outstanding Number Exercisable Exercise Price Weighted Average Life (years) Expiry Date January 3, 2022 125,000 - USD 0.65 9.77 January 3, 2032 January 4, 2022 5,875,000 - USD 0.65 9.77 January 4, 2032 Total 6,000,000 - USD 0.65 9.77
Schedule for the Company's outstanding performance stock units:	Number of Options Weighted Average Exercise Price Outstanding, June 30, 2021 - $ - Granted 4,000,000 - Released - - Forfeited or cancelled - - Outstanding, March 31, 2022 4,000,000 $ -

ORGANIZATION AND DESCRIPTION _2

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Narrative)	9 Months Ended
	Mar. 31, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS
Entity Incorporation, Date of Incorporation	Sep. 06, 2019

GOING CONCERN UNCERTAINTY (Deta

GOING CONCERN UNCERTAINTY (Details Narrative) - USD ($)	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
GOING CONCERN UNCERTAINTY
Working Capital (deficit) Surplus	$ 630,773	$ 652,296
Accumulated deficit	$ (2,908,132)	$ (1,000,382)	$ (77,202)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Software Useful Life		5 years
Software [Member]
Software Useful Life	5 years

SOFTWARE (Details)

SOFTWARE (Details) - USD ($)	9 Months Ended	10 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2020	Jun. 30, 2021
SOFTWARE
Software, Beginning	$ 75,750	$ 0	$ 21,500
Additions	243,650	21,500	54,250
Depreciation	0	0	0
Software, ending	$ 319,400	$ 21,500	$ 75,750

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Management Fees			$ 134,750	$ 29,700
Due To Director			$ 0	$ 1,308
Chris White [Member]
Management Fees	$ 12,500	$ 0
Net wages	25,620	0
Troy Wilkinson [Member]
Management Fees	107,500	0
Shannon Wilkinson [Member]
Management Fees	66,500	81,000
Net wages	$ 34,099	$ 0

COMMON SHARES (Details)

COMMON SHARES (Details) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
SHAREHOLDERS' EQUITY
Number of warrants outstanding, beginning	3,014,246	0
Number of warrants granted	0	3,014,246
Number of warrants exercised	0	0
Number of warrants expired	0	0
Number of warrants outstanding, ending	3,014,246	3,014,246
Weighted average exercise price outstanding, beginning	$ 0.25	$ 0
Weighted average exercise price granted	0	0.25
Weighted average exercise price exercised	0	0
Weighted average exercise price expired	0	0
Weighted average exercise price outstanding, ending	$ 0.25	$ 0.25

COMMON SHARES (Details 1)

COMMON SHARES (Details 1) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Number of warrants outstanding, beginning	3,014,246	0
Number of non qualified stock options granted	0	3,014,246
Number of warrants outstanding, ending	3,014,246	3,014,246
Weighted average exercise price outstanding, beginning	$ 0.25	$ 0
Weighted average exercise price granted	0	0.25
Weighted average exercise price outstanding, ending	$ 0.25	$ 0.25
Options Held [Member]
Number of warrants outstanding, beginning	0
Number of non qualified stock options granted	6,000,000
Number of warrants outstanding, ending	6,000,000	0
Weighted average exercise price outstanding, beginning	$ 0
Weighted average exercise price granted	0.65
Weighted average exercise price outstanding, ending	$ 0.65	$ 0

COMMON SHARES (Details 2)

COMMON SHARES (Details 2) - $ / shares	9 Months Ended
	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
Number of option outstanding	3,014,246	3,014,246	0
January 3, 2022 [Member]
Number of option outstanding	125,000
Exercise	$ 0.65
Expiry Date	January 3, 2032
Average life	9 years 9 months 7 days
January 4, 2022 [Member]
Number of option outstanding	5,875,000
Exercise	$ 0.65
Expiry Date	January 4, 2032
Average life	9 years 9 months 7 days
Options Held [Member]
Number of option outstanding	6,000,000	0
Exercise	$ 0.65
Average life	9 years 9 months 7 days

COMMON SHARES (Details 3)

COMMON SHARES (Details 3) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Expected life	10 years	2 years
Expected dividend rate	0%	0%
Expected volatility	106.83%
Minimum
Expected volatility		102.03%
Stock Price		$ 0.85
Risk-free Interest Rate	1.63%	0.13%
Maximum
Expected volatility		206.63%
Stock Price		$ 0.25
Risk-free Interest Rate	1.66%	0.17%

COMMON SHARES (Details 4)

COMMON SHARES (Details 4) - $ / shares	9 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Number of warrants outstanding, beginning	3,014,246	0
Number Of Warrants Granted	0	3,014,246
Number Of Warrants Exercised	0	0
Number Of Warrants Expired	0	0
Number of warrants outstanding, ending	3,014,246	3,014,246
Weighted average exercise price outstanding, beginning	$ 0.25	$ 0
Weighted Average Exercise Price Granted	0	0.25
Weighted Average Exercise Price Exercised	0	0
Weighted Average Exercise Price Expired	0	0
Weighted average exercise price outstanding, ending	$ 0.25	$ 0.25
Performance Shares [Member]
Number of warrants outstanding, beginning	0
Number Of Warrants Granted	4,000,000
Number Of Warrants Exercised	0
Number Of Warrants Expired	0
Number of warrants outstanding, ending		0
Weighted Average Exercise Price Granted	$ 0
Weighted Average Exercise Price Exercised	0
Weighted Average Exercise Price Expired	$ 0
Number of warrants outstanding, ending	4,000,000
Weighted Average Exercise Price Outstanding, Beginning	$ 0
Weighted Average Exercise Price Outstanding, Ending	$ 0	$ 0

COMMON SHARES (Details Narrativ

COMMON SHARES (Details Narrative) - USD ($)					1 Months Ended		3 Months Ended		9 Months Ended		10 Months Ended	12 Months Ended
	Apr. 28, 2021	Apr. 22, 2021	Mar. 25, 2021	Dec. 28, 2020	Mar. 29, 2021	Jul. 31, 2020	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2020	Jun. 30, 2021
Share based compensation									$ 386,449
Common Stock, Authorized							50,000,000		50,000,000		50,000,000	50,000,000
Common stock, authorized							50,000,000		50,000,000		50,000,000	50,000,000
Common Stock, Par Value							$ 0.001		$ 0.001		$ 0.001	$ 0.001
Common Stock, Issued							25,108,044		25,108,044		0	18,296,511
Common stock, issued							25,108,044		25,108,044		0	18,296,511
Non qualified stock options							6,000,000		6,000,000
Exercise price							$ 0.65		$ 0.65
Performance stock units							4,000,000		4,000,000
Common Stock, Outstanding							25,108,044		25,108,044		0	18,296,511
Number Of Warrants Granted									0			3,014,246
Weighted Average Exercise Price Granted									$ 0			$ 0.25
Weighted Average Remaining Contractual Life Of Warrants Outstanding												1 year 2 months 15 days
Legal services valued							$ 45,435	$ 17,820	$ 197,442	$ 101,810	$ 26,429	$ 168,077
October 15, 2021
Common Stock, Issued							125,000		125,000
Common stock, issued							125,000		125,000
Prepaid marketing services									$ 100,000
Advertising and promotion expenses									$ 75,138
Share price							$ 0.80		$ 0.80
October 28, 2021
Common Stock, Issued							28,572		28,572
Common stock, issued							28,572		28,572
Share price							$ 0.70		$ 0.70
Legal services valued									$ 20,000
December 31, 2021
Common Stock, Issued							937,151		937,151
Common stock, issued							937,151		937,151
Net value									$ 93,715
Conversion price							$ 0.10		$ 0.10
January 1, 2022
Common Stock, Issued							100,000		100,000
Common stock, issued							100,000		100,000
Share price							$ 0.65		$ 0.65
Legal services valued									$ 65,000
Consulting expenses									$ 15,893
March 25, 2022
Common Stock, Issued							12,000		12,000
Common stock, issued							12,000		12,000
Share price							$ 0.60		$ 0.60
Services valued									$ 7,200
December 8, 2021
Common Stock, Issued							50,000		50,000
Common stock, issued							50,000		50,000
Share price							$ 0.71		$ 0.71
Legal services valued									$ 35,250
Consulting expenses									$ 14,526
Warrant [Member]
Number Of Warrants Granted	307,408	506,838	1,100,000	1,100,000
Weighted Average Exercise Price Granted	$ 0.25	$ 0.25	$ 0.25	$ 0.25
Weighted Average Remaining Contractual Life Of Warrants Outstanding	2 years	2 years	2 years	2 years
Fair value of warrant granted	$ 196,399	$ 399,087	$ 147,266	$ 145,744
Common Shares [Member]
Share price					$ 0.25	$ 0.05	$ 0.50		$ 0.50
Stock issued					100,000	500,000	100,000		100,000
Proceeds from share issued						$ 25,000			$ 1,425,202
Conversion of common stock value					$ 25,000
Common Shares [Member] | Non-Related Party [Member]
Share price				$ 0.10	$ 0.25
Stock issued				110,000	88,000
Proceeds from share issued				$ 11,000	$ 12,000
Common Shares [Member] | Private Placement [Member]
Share price							$ 0.25	$ 0.25	$ 0.25	$ 0.25
Net value										$ 49,500
Stock issued							5,458,810	196,000	5,458,810	196,000

COVERTIBLE DEBTS (Details Narra

COVERTIBLE DEBTS (Details Narrative) - USD ($)		1 Months Ended		9 Months Ended		10 Months Ended	12 Months Ended
	Nov. 10, 2020	Apr. 28, 2021	Apr. 22, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Total proceeds issued a convertible debt				$ 0	$ 260,000	$ 0	$ 300,000
Extinguishment of convertible debt						$ 0	$ 36,731	$ 0
Convertible Debt [Member]
Convertible debt in exchange for cash	$ 20,000		$ 55,245
Convertible debt in exchange for cash, fair value			50,684
Additional cash proceeds			$ 30,000
Warrants issued			506,838
Warrant exercisable			$ 0.25
Original issue discount			$ 4,561
Convertible interest rate	8%		8%
Total proceeds issued a convertible debt	$ 20,000
Fair value			$ 44,088
Extinguishment of convertible debt			$ 18,049
Beneficial conversion features					5,912
Carrying value of convertible debt					0
Conversion of common stock value					$ 58,394
Conversion of common stock shares issued					583,936
Convertible Debt One [Member]
Convertible debt in exchange for cash	$ 20,000	$ 33,508
Convertible debt in exchange for cash, fair value		30,741
Additional cash proceeds		$ 10,000
Warrants issued		307,408
Warrant exercisable		$ 0.25
Original issue discount		$ 2,767
Convertible interest rate	8%	8%
Total proceeds issued a convertible debt	$ 20,000
Fair value		$ 25,745
Extinguishment of convertible debt		$ 18,682
Beneficial conversion features					$ 4,255
Conversion of common stock value					$ 35,321
Conversion of common stock shares issued					353,215
Debt instrument interest rate					12%

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2020
INCOME TAXES
Net operating loss carry forward	$ 2,552,102	$ 741,817	$ 79,527

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)	9 Months Ended
	Mar. 31, 2022
COMMITMENTS AND CONTINGENCIES
Lessee, Operating Lease, Term of Contract	12 years
Lessee, Operating Lease, Description	The Company leases its corporate office located at 8565 S. Eastern Ave. #150, Las Vegas, Nevada. The initial lease term is for 12 months commencing on September 8, 2019 after which the term is on a month-to-month basis. After the initial term, the Company may cancel the lease agreement at any time by providing 30 days written notice. The Company has elected the short-term lease practical expedient of 12 months and has not recorded a lease.